A

A

ANOTA , Amelie

Last name: ANOTA

First name: Amelie

October 18, 2017 (v1)

Conference paper

Metadata-only

Minimal clinically important difference for the EORTC QLQ-C30 and QLQ-BN20 questionnaires in glioblastoma patients using several distribution and anchor-based methods

Ousmen, Ahmad Anota, Amelie Chauffert, Bruno

Many researches have been conducted in the last decades on the determination of the minimal clinically important difference(MCID) for health-related quality of life (HRQOL) scores. Several methods have been proposed, generally classified in distribution oranchor-based methods. A joint use of both distribution and anchorbased approaches, using...

Uploaded on: December 3, 2022
August 2018 (v1)

Journal article

Metadata-only

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Kim, Stefano François, Eric André, Thierry

BackgroundThe incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades. Currently, there is no validated treatment for advanced-stage anal squamous cell carcinoma. Therefore, we aimed to validate the clinical activity and safety of docetaxel, cisplatin, and fluorouracil (DCF) chemotherapy in patients with...

Uploaded on: December 4, 2022